19 results
8-K
RTSL
Rapid Therapeutic Science Laboratories, Inc.
18 Jan 22
Departure of Directors or Certain Officers
1:54pm
a written consent in lieu of a special meeting of shareholders (the “Majority Shareholder Consent”), approving the actions described below, which had … 750,000,000 to 800,000,000 (the “Amendment”).
The Board did not solicit proxies for the special meeting or the vote. There were no broker non-votes
10-KT
EX-4.1
RTSL
Rapid Therapeutic Science Laboratories, Inc.
16 Mar 21
Annual report (with FYE transition)
4:04pm
; and
·the requirement that a special meeting of stockholders may be called only by either (i) the Chairman; (ii) the President; or (iii) one or more stockholders
8-K
RTSL
Rapid Therapeutic Science Laboratories, Inc.
31 Mar 22
Announces 1-for-25 Reverse Stock Split
4:43pm
”), representing an aggregate of 51.4% of the total voting shares as of such date, executed a written consent in lieu of a special meeting of shareholders
8-K
EX-10.2
RTSL
Rapid Therapeutic Science Laboratories, Inc.
21 Jan 22
Entry into a Material Definitive Agreement
9:36am
written notice (but in any event at least five (5) days prior written notice) of the record date of the special meeting of shareholders to approve
8-K
EX-10.2
2gy8lr 3bhwt
1 Feb 22
Entry into a Material Definitive Agreement
11:11am
PRE 14C
252oqz1tzi6004r31as4
30 Dec 21
Preliminary information
2:18pm
DEF 14C
zelepu
14 Jan 22
Information statement
4:08pm
DEF 14C
p7kl qjgfa3i9yw
31 Dec 20
Information statement
1:50pm
PRE 14C
0t4u 3d1v6
18 Dec 20
Preliminary information
5:02pm
- Prev
- 1
- Next